Ike Calls for Urgent Action Against Gonorrhea Resistance

Ike, a former resident physician at the University of Nigeria Teaching Hospital, stresses the importance of intensifying Nigeria's efforts against drug-resistant gonorrhea. He notes that Neisseria gonorrhoeae has been classified as an urgent threat by the CDC, with ceftriaxone being the last reliable first-line treatment.

Resistance to this antibiotic is already being documented globally, and losing it would leave no effective oral treatment options for gonorrhea. Ike points out that Nigeria faces a particularly high burden of sexually transmitted infections, with gonorrhea being endemic.

He highlights the inadequacies in Nigeria's surveillance infrastructure for monitoring antibiotic resistance, which could lead to catastrophic outcomes. The CDC's National Antimicrobial Resistance Monitoring System has a strategic plan prioritizing gonorrhea resistance surveillance from 2026 to 2030, but the stakes are higher in Nigeria due to its significant STI burden and underfunded healthcare systems.